(P326) |
The serum- and glucocorticoid-regulated kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. |
|
R.S. Belaiba, T. Djordjevic, S. Bonello, F. Lang, J. Hess, A. Görlach (München and Tübingen, DE) |
(P327) |
Arterial hypotension and vascular hypocontractility in cirrhotic rats is associated with impairment of RhoA/Rho-kinase-mediated vasocontraction. |
|
M. Hennenberg, J. Trebicka, K. Jochem, E. Biecker, T. Sauerbruch, J. Heller (Bonn, DE) |
(P328) |
The effects of ghrelin on adenylyl cyclase and phosphalipase C activity in rat aorta. |
|
F. Ademoglu, N. Abacýoglu, E. Baloglu, H. Gurdal (Ankara, TR) |
(P329) |
Transforming growth factor alpha transduces the activation of NF-kB but not ERK1/2 by high intraluminal pressure in the vascular wall. |
|
C. Lemarie, B. Esposito, P-L. Tharaux, A. Tedgui, S. Lehoux (Paris, FR) |
(P330) |
Role of the factor VII activating protease (FSAP) in vascular smooth muscle cell proliferation and neointima formation. |
|
D. Sedding, J-M. Daniel, L. Muhl, H. Brunsch, K. Hersemeyer, R. Braun-Dullaeus, H. Tillmanns, B. Kemkes-Matthes, K. Preissner, S. Kanse (Gießen and Dresden, DE) |
(P331) |
Characterisation of outward current in isolated rat coronary artery myocytes. |
|
C. Prendergast, J. Quayle, T. Burdyga, S. Wray (Liverpool, GB) |
(P332) |
Rac and PAK promote plasminogen activator inhibitor-1 expression and proliferation of pulmonary artery smooth muscle cells involving hypoxia-inducible factor-1. |
|
T. Djordjevic, R.S. Belaiba, I. Diebold, T. Kietzmann, J. Hess, A. Görlach (München and Kaiserslautern, DE) |
(P333) |
Gender differences in vascular reactivity to levosimendan in rat aortic rings. |
|
G. Szabó, L. Seres, T. Radovits, S. Hagl (Heidelberg, DE) |
(P334) |
Effects of rapamycin on neointimal and medial smooth muscle cells. |
|
W. Dichtl, E-M. Stocker, Z-Q. Yan, H.F. Alber, M. Frick, J. Dulak, O. Pachinger, F. Weidinger (Innsbruck, AT; Stockholm, SE; Krakow, PL) |
(P335) |
Inhibitors of histone deacetylation suppress the activation of the MAPK signaling and block the proliferation of human cSMC. |
|
T. Gierse, K. Peters, H. Kneer, J. Leng, H. Eschert, F. Jesacher, P. Loidl, M. Jung, A. Skaletz-Rorowski (Münster, Mainz and Freiburg, DE; Innsbruck, AT) |
(P336) |
The forkhead transcription factor FoxO1a regulates cellular Caveolin-1 expression: impact on apoptosis of vascular smooth muscle cells. |
|
D. Sedding, S. Vogel, H. Tillmanns, R. Braun-Dullaeus (Gießen and Dresden, DE) |
(P337) |
Conditional ablation of vascular smooth muscle cells: direct effects of cell death on normal arteries and in atherosclerosis. |
|
M. Clarke, N. Figg, J. Maguire, A. Davenport, M. Goddard, T. Littlewood, M. Bennett (Cambridge, GB) |
(P338) |
Desensitisation of the cardiac PTH-receptor contributes to the paradoxical vasoconstriction mediated by bioactive PTH-peptides. |
|
G. Ross, A. Dolf, E. Bahner, K-D. Schlüter (Gießen, DE) |
(P339) |
The contraction of smooth muscle cells is inhibited by interleukin-1, as detected in a three dimensional collagen gel assay. |
|
Y. Shi, B. Li, U. Müller-Werdan, K. Werdan, H. Loppnow (Halle/Saale, DE) |
(P340) |
Profiling of aortic smooth muscle cells gene expression during aging in rats. |
|
S. Nadaud, L. Monnet, J-B. Michel, S. Raoux, B. Corman, F. Soubrier (Paris, FR) |